Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Epidemiological Study to Describe NSCLC Clinical Management Patterns in Europe. Lung-EPICLIN

This study has been completed.
Sponsor:
Information provided by:
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00831909
First received: January 28, 2009
Last updated: August 9, 2010
Last verified: August 2010